ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 1, p. 166, doi. 10.1002/med.20209
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2012 AND VI 32 AND IP 1
Results: 3
1
2
Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 1, p. 1, doi. 10.1002/med.20200
- By:
- Publication type:
- Article
3
New definitions of extended-spectrum β-lactamase conferring worldwide emerging antibiotic resistance.
- Published in:
- Medicinal Research Reviews, 2012, v. 32, n. 1, p. 216, doi. 10.1002/med.20210
- By:
- Publication type:
- Article